ArticleFrontiers in medicine2026
Using supplementary formula of Qing-Hao-Bie-Jia decoction for defervescence of lung cancer-related fever: a literature review and case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer-related fever is a common complication of lung cancer that negatively affects patients' quality of life. Recently, Qing-Hao-Bie-Jia Decoction (QHBJD), as a representative Traditional Chinese Medicine (TCM) formula historically used to treat endogenous heat caused by Yin deficiency, has been increasingly applied in the management of lung cancer-related fever (LCRF). Our investigation endeavored to establish a chain of evidence bridging classical TCM theory and contemporary clinical practice toward the application of QHBJD in treating LCRF as a methodological reference in the real-world setting. Methods: Our study was made up of three parts: 1) Ancient origins of QHBJD from pre-modern Chinese medical texts; 2) systematic review of QHBJD for treating LCRF from published case reports; 3) a case report treated with QHBJD-derived supplementary formula from our clinical practice. Results: From our findings, "latent heat in the Yin" is the predominant pathogenesis of cancerous fever among lung cancer patients, who are mainly treated with the therapeutic principle of nourishing Yin and outthrusting heat. In addition, the pathogenesis of included LCRF case reports is complicated, but TCM practitioners can support vital-qi and eliminate pathogenic factors by flexibly adding or subtracting Chinese medicines based on QHBJD for treatment. Conclusion: In this study, we established a methodological framework merging ancient and modern evidence based on case reports, which prospectively aids future TCM studies in enhancing certainty of the same evidence from empirical medicine to evidence-based medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.